Gabapentin
Product Images NDC 50436-7284

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50436-7284). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Capsules Usp 1)

A mathematical formula image illustrating the calculation of creatinine clearance (CLCr), which factors in patient age, weight, serum creatinine levels, and includes an adjustment multiplier for female patients.*

FDA Label Image

Structural Formula (Gabapentin Capsules Usp 2)

Chemical structure diagram of gabapentin showing its cyclohexane ring bonded to an aminomethyl and a carboxymethyl group.*

FDA Label Image

Figure 1 (Gabapentin Capsules Usp 3)

A line graph showing the mean pain score over 8 weeks comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows the mean pain score from 0 to 10, with the Gabapentin group showing a decreasing pain score over time compared to the placebo group.*

FDA Label Image

Figure 2 (Gabapentin Capsules Usp 4)

Line graph depicting mean pain scores over seven weeks comparing placebo with Gabapentin at 1800 mg/day and 2400 mg/day doses. The x-axis represents weeks, divided into a 3-week dose titration period and a 4-week fixed dose period, while the y-axis shows the mean pain score on a scale from 0 to 10.*

FDA Label Image

Figure 3 (Gabapentin Capsules Usp 5)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares placebo (PBO) and Gabapentin (GBP) at doses of 1800, 2400, and 3600 mg across two studies, showing higher responder percentages for Gabapentin groups than placebo, with statistical significance indicated by p-values below 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gabapentin Capsules Usp 6)

A scatter plot depicting the percentage difference against daily dose in mg for Gabapentin across three studies labeled a, b, and c. The x-axis represents daily dose ranging from 600 to 1800 mg, and the y-axis represents the difference percentage from 2 to 22%. Study a is marked with black squares, study b with grey squares, and study c with white squares, showing data points at various doses with differences annotated by letters.*

FDA Label Image

Label Image (Lbl504367284)

Gabapentin 400 mg capsule strip label showing 30 capsules per package. The label includes the National Drug Code (NDC) 50436-7284-1, manufacturer Unit Dose Services, LLC, located in Miami, FL, and placeholders for lot number and expiration date. Storage and warning instructions are also present, emphasizing controlled room temperature and keeping out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.